ASLAN snags debt financing from K2 HealthVentures
K2 HealthVentures has provided up to $45 million in debt financing from ASLAN Pharmaceuticals, an clinical-stage immunology focused biopharmaceutical company.
K2 HealthVentures has provided up to $45 million in debt financing from ASLAN Pharmaceuticals, an clinical-stage immunology focused biopharmaceutical company.
Copyright PEI Media
Not for publication, email or dissemination